MedTrace Logo

Efficacy and Safety of iStent in Reducing Intraocular Pressure in Open-angle Glaucoma

NCT07354009 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-01-21

No results posted yet for this study

Summary

To evaluate the efficacy and safety of istent inject W in reducing intraocular pressure in Chinese adult patients with open-angle glaucoma complicated with cataract.

Conditions

Interventions

PROCEDURE

PHACO+PC-IOL+iStent

PHACO+PC-IOL+iStent

PROCEDURE

PHACO+PC-IOL

PHACO+PC-IOL

Sponsors & Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • Kaijun Wang · Eye Center, the 2nd Affiliated Hospital, Medical College of Zhejiang Universit

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-07
Primary Completion
2026-10-01
Completion
2027-10-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07354009 on ClinicalTrials.gov